A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain

NCT00099177 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Bone Neoplasm
Neoplasm Metastasis

Interventions

DRUG: ibandronate [Bondronat]
DRUG: zoledronic acid

Sponsor

Hoffmann-La Roche